Nucana to present data on nuc-7738's synergy with pd-1 inhibitors at the esmo congress 2025

Edinburgh, united kingdom, sept. 03, 2025 (globe newswire) -- nucana plc (nasdaq: ncna) (“nucana” or the “company”) announced a presentation at the upcoming annual european society for medical oncology (“esmo”) congress being held october 17-21, 2025 in berlin, germany (the “esmo congress 2025”).
NCNA Ratings Summary
NCNA Quant Ranking